HCPCS Level II
J1160
Injection, digoxin, up to 0.5 mg
Codes near J1160
These sit next to J1160 in the CMS Level II file. All J codes
- J1100Injection, dexamethasone sodium phosphate, 1 mg
- J1105Dexmedetomidine, oral, 1 mcg
- J1110Injection, dihydroergotamine mesylate, per 1 mg
- J1120Injection, acetazolamide sodium, up to 500 mg
- J1130Injection, diclofenac sodium, 0.5 mg
- J1162Injection, digoxin immune fab (ovine), per vial
- J1163Injection, diltiazem hydrochloride, 0.5 mg
- J1164Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165Injection, phenytoin sodium, per 50 mg
- J1170Injection, hydromorphone, up to 4 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00404-9850-02 | Digoxin | Henry Schein Inc. | 1 |
| 00641-1410-35 | Digoxin | Hikma Pharmaceuticals USA Inc. | 25 |
| 00641-6184-25 | Digoxin | Hikma Pharmaceuticals USA Inc. | 25 |
| 00781-3059-95 | Digoxin | Sandoz Inc. | 10 |
| 51662-1217-01 | Digoxin | HF Acquisition Co. LLC, DBA HealthFirst | 1 |
| 51662-1217-03 | Digoxin | HF Acquisition Co. LLC, DBA HealthFirst | 25 |
| 70515-0260-10 | Lanoxin | Covis Pharma US, Inc | 10 |
| 70515-0261-10 | Lanoxin | Covis Pharma US, Inc | 10 |
| 70515-0262-10 | Lanoxin | Covis Pharma US, Inc | 2 |
| 70515-0263-10 | Lanoxin | Covis Pharma US, Inc | 2 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.